中华神经医学杂志
中華神經醫學雜誌
중화신경의학잡지
CHINESE JOURNAL OF NEUROMEDICINE
2013年
11期
1136-1140
,共5页
周劲旭%陈菊祥%徐涛%秦荣%严勇%陈超%卢亦成
週勁旭%陳菊祥%徐濤%秦榮%嚴勇%陳超%盧亦成
주경욱%진국상%서도%진영%엄용%진초%로역성
神经胶质瘤%岛叶%总体生存时间%无进展生存期%切除程度
神經膠質瘤%島葉%總體生存時間%無進展生存期%切除程度
신경효질류%도협%총체생존시간%무진전생존기%절제정도
Glioma%Insular%Overall survival%Progression-free survival%Extent of resection
目的 探讨影响岛叶胶质瘤患者预后的主要因素. 方法 回顾性分析上海长征医院神经外科自2002年4月至2011年4月采用显微手术治疗的58例岛叶胶质瘤患者的临床资料,通过随访获得其总体生存时间(OS)和无进展生存期(PFS),对影响患者预后的因素分别进行单因素(Log rank检验)及多因素(Cox回归)分析. 结果 58例岛叶胶质瘤患者均接受显微手术治疗,其中33例(56.9%)全切除,12例(20.7%)次全切除,12例(20.7%)部分切除,1例(1.7%)活检.24例(24/26,92.3%)高级别胶质瘤患者在术后接受规范化的放化疗,21例(21/32,65.6%)低级别胶质瘤术后接受了放化疗.58例患者的OS中位值为29.0月,PFS中位值为25.0月;5年生存率为46%,截至随访结束生存率为33%.统计结果表明术前Karnofsky功能状态评分(KPS)、病理级别及切除程度是影响患者预后的独立因素. 结论 岛叶胶质瘤的显微手术应在保护重要血管穿支及功能区,避免发生并发症的情况下尽可能最大程度切除肿瘤,藉此可显著改善患者预后.
目的 探討影響島葉膠質瘤患者預後的主要因素. 方法 迴顧性分析上海長徵醫院神經外科自2002年4月至2011年4月採用顯微手術治療的58例島葉膠質瘤患者的臨床資料,通過隨訪穫得其總體生存時間(OS)和無進展生存期(PFS),對影響患者預後的因素分彆進行單因素(Log rank檢驗)及多因素(Cox迴歸)分析. 結果 58例島葉膠質瘤患者均接受顯微手術治療,其中33例(56.9%)全切除,12例(20.7%)次全切除,12例(20.7%)部分切除,1例(1.7%)活檢.24例(24/26,92.3%)高級彆膠質瘤患者在術後接受規範化的放化療,21例(21/32,65.6%)低級彆膠質瘤術後接受瞭放化療.58例患者的OS中位值為29.0月,PFS中位值為25.0月;5年生存率為46%,截至隨訪結束生存率為33%.統計結果錶明術前Karnofsky功能狀態評分(KPS)、病理級彆及切除程度是影響患者預後的獨立因素. 結論 島葉膠質瘤的顯微手術應在保護重要血管穿支及功能區,避免髮生併髮癥的情況下儘可能最大程度切除腫瘤,藉此可顯著改善患者預後.
목적 탐토영향도협효질류환자예후적주요인소. 방법 회고성분석상해장정의원신경외과자2002년4월지2011년4월채용현미수술치료적58례도협효질류환자적림상자료,통과수방획득기총체생존시간(OS)화무진전생존기(PFS),대영향환자예후적인소분별진행단인소(Log rank검험)급다인소(Cox회귀)분석. 결과 58례도협효질류환자균접수현미수술치료,기중33례(56.9%)전절제,12례(20.7%)차전절제,12례(20.7%)부분절제,1례(1.7%)활검.24례(24/26,92.3%)고급별효질류환자재술후접수규범화적방화료,21례(21/32,65.6%)저급별효질류술후접수료방화료.58례환자적OS중위치위29.0월,PFS중위치위25.0월;5년생존솔위46%,절지수방결속생존솔위33%.통계결과표명술전Karnofsky공능상태평분(KPS)、병리급별급절제정도시영향환자예후적독립인소. 결론 도협효질류적현미수술응재보호중요혈관천지급공능구,피면발생병발증적정황하진가능최대정도절제종류,자차가현저개선환자예후.
Objective To investigate the factors affecting the prognosis of insular gliomas.Methods A series of 58 insular gliomas patients,admitted to and received microsurgical treatment in our hospital from April 2002 to April 2011,were chosen in our study; their clinical data were retrospectively reviewed and analyzed.The overall survival time (OS) and progression-free survival time (PFS) were calculated; univariate analysis (Log rank test) and multivariate analysis (Cox regression) were used to estimate the risk factors for patients' prognosis.Results The majority of 58 patients received aggressive treatment,with gross total resection in 33 (56.9%),sub-total resection in 12 (20.7%),partial resection in 12 (20.7%) and biopsy in only 1 (1.7%).In all,92.3% high-grade gliomas patients (24/26)received adjuvant chemotherapy and radiotherapy.In 32 low-grade gliomas patients,21 (65.6%) received adjuvant chemotherapy and radiotherapy.The median OS was 29.0 months,and the median PFS was 25.0 months.Five years of survival rate was 46%,and till the follow-up deadline,the survival rate was 33%.KPS,grade of pathology and extent of resection were the independent prognostic factors for both OS and PFS.Conclusion In the protection of important structures and avoidance of complications,an aggressive management of optimal resection is associated with better outcome in patients with insular gliomas.